# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001144204-14-062642
Filing Date
2014-10-24
Accepted
2014-10-23 20:31:20
Documents
26
Period of Report
2014-10-24
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 8-K | v392039_8k.htm | 8-K | 16333
2 | EXHIBIT 99.1 | v392039_ex99-1.htm | EX-99.1 | 44797
3 | GRAPHIC | image_001.jpg | GRAPHIC | 46354
4 | GRAPHIC | image_002.jpg | GRAPHIC | 121930
5 | GRAPHIC | image_003.jpg | GRAPHIC | 125416
6 | GRAPHIC | image_004.jpg | GRAPHIC | 123771
7 | GRAPHIC | image_005.jpg | GRAPHIC | 163250
8 | GRAPHIC | image_006.jpg | GRAPHIC | 110224
9 | GRAPHIC | image_007.jpg | GRAPHIC | 133096
10 | GRAPHIC | image_008.jpg | GRAPHIC | 114079
11 | GRAPHIC | image_009.jpg | GRAPHIC | 118733
12 | GRAPHIC | image_010.jpg | GRAPHIC | 130683
13 | GRAPHIC | image_011.jpg | GRAPHIC | 134620
14 | GRAPHIC | image_012.jpg | GRAPHIC | 111133
15 | GRAPHIC | image_013.jpg | GRAPHIC | 124216
16 | GRAPHIC | image_014.jpg | GRAPHIC | 108710
17 | GRAPHIC | image_015.jpg | GRAPHIC | 86939
18 | GRAPHIC | image_016.jpg | GRAPHIC | 89369
19 | GRAPHIC | image_017.jpg | GRAPHIC | 99434
20 | GRAPHIC | image_018.jpg | GRAPHIC | 110571
21 | GRAPHIC | image_019.jpg | GRAPHIC | 144713
22 | GRAPHIC | image_020.jpg | GRAPHIC | 136554
23 | GRAPHIC | image_021.jpg | GRAPHIC | 114472
24 | GRAPHIC | image_022.jpg | GRAPHIC | 113844
25 | GRAPHIC | image_023.jpg | GRAPHIC | 64596
26 | GRAPHIC | image_024.jpg | GRAPHIC | 125716
| Complete submission text file | 0001144204-14-062642.txt |  | 3858217

Mailing Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207
Business Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207 2149055100
PLASMATECH BIOPHARMACEUTICALS INC (Filer) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-15771 | Film No.: 141170972
SIC: 2834 Pharmaceutical Preparations